US Stock MarketDetailed Quotes

NVST Envista Holdings

  • 18.250
  • +0.280+1.56%
Close May 24 16:00 ET
  • 18.250
  • 0.0000.00%
Post 16:40 ET
3.14BMarket Cap-25000P/E (TTM)

About Envista Holdings Company

Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. It operates through Specialty Products and Technologies, and Equipment and Consumables segments. The Specialty Products and Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment and Consumables segments develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems, handpieces and associated consumables, treatment units and other dental practice equipment, endodontic systems and related consumables, restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products. It offers dental consumables, equipment, and services to dental professionals. The company was founded on August 29, 2018, and is headquartered in Brea, CA.

Company Profile

Company NameEnvista Holdings
Listing DateSep 18, 2019
Issue Price22.00
CEOMr. Paul A. Keel
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address200 South Kraemer Boulevard,Building E
CountryUnited States of America
Zip Code92821

Company Executives

  • Name
  • Position
  • Salary
  • Paul A. Keel
  • Director, President and Chief Executive Officer
  • --
  • Faez C. Kaabi
  • Vice President and Chief Accounting Officer
  • --
  • Stephen Keller
  • Principal Financial Officer and Vice President, Investor Relations
  • 703.93K
  • Mischa M. Reis
  • Senior Vice President, Strategy and Corporate Development
  • --
  • Eric Conley
  • Senior Vice President and President, Orthodontics
  • 2.12M
  • Mark E. Nance
  • Senior Vice President, General Counsel and Secretary
  • 1.54M
  • R. Scott Huennekens
  • Chairman of the Board
  • 435.09K
  • Robert Befidi
  • President, Diagnostics
  • --
  • Christine A. Tsingos
  • Independent Director
  • 310.05K
  • Daniel A. Raskas
  • Independent Director
  • 285.05K
  • Kieran T. Gallahue
  • Independent Director
  • 300.05K
  • Vivek Jain
  • Independent Director
  • 285.05K
  • Barbara B. Hulit
  • Independent Director
  • 285.05K
  • Wendy Carruthers
  • Independent Director
  • 305.05K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price